» Articles » PMID: 33291597

Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 9
PMID 33291597
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Adiponectin is an adipokine produced by adipose tissue. It has numerous beneficial effects. In particular, it improves metabolic effects and glucose homeostasis, lipid profile, and is involved in the regulation of cytokine profile and immune cell production, having anti-inflammatory and immune-regulatory effects. Adiponectin's role is already known in immune diseases and also in neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are a set of diseases of the central nervous system, characterized by a chronic and selective process of neuron cell death, which occurs mainly in relation to oxidative stress and neuroinflammation. Lifestyle is able to influence the development of these diseases. In particular, unhealthy nutrition on gut microbiota, influences its composition and predisposition to develop many diseases such as neurodegenerative diseases, given the importance of the "gut-brain" axis. There is a strong interplay between Adiponectin, gut microbiota, and brain-gut axis. For these reasons, a healthy diet composed of healthy nutrients such as probiotics, prebiotics, polyphenols, can prevent many metabolic and inflammatory diseases such as neurodegenerative diseases and obesity. The special Adiponectin role should be taken into account also, in order to be able to use this component as a therapeutic molecule.

Citing Articles

AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.

Barbalho S, Fornari Laurindo L, de Oliveira Zanuso B, da Silva R, Gallerani Caglioni L, Nunes Junqueira de Moraes V Int J Mol Sci. 2025; 26(2).

PMID: 39859201 PMC: 11765103. DOI: 10.3390/ijms26020484.


Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials.

Park K, Gao Y Front Neurosci. 2024; 18:1481390.

PMID: 39513042 PMC: 11541110. DOI: 10.3389/fnins.2024.1481390.


Exercise, Neuroprotective Exerkines, and Parkinson's Disease: A Narrative Review.

Mitchell A, Bliss R, Church F Biomolecules. 2024; 14(10).

PMID: 39456173 PMC: 11506540. DOI: 10.3390/biom14101241.


From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders.

Duranti E, Villa C Biology (Basel). 2024; 13(9).

PMID: 39336146 PMC: 11428675. DOI: 10.3390/biology13090719.


Body Composition and Alzheimer's Disease: A Holistic Review.

Frank G, Gualtieri P, Cianci R, Caldarelli M, Palma R, De Santis G Int J Mol Sci. 2024; 25(17).

PMID: 39273520 PMC: 11395597. DOI: 10.3390/ijms25179573.


References
1.
Luna R, Foster J . Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr Opin Biotechnol. 2014; 32:35-41. DOI: 10.1016/j.copbio.2014.10.007. View

2.
Li Q, Lu Y, Sun L, Yan J, Yan X, Fang L . Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism. 2012; 61(12):1803-8. DOI: 10.1016/j.metabol.2012.06.001. View

3.
Perez-Burgos A, Wang B, Mao Y, Mistry B, McVey Neufeld K, Bienenstock J . Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am J Physiol Gastrointest Liver Physiol. 2012; 304(2):G211-20. DOI: 10.1152/ajpgi.00128.2012. View

4.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

5.
Polito R, Nigro E, Pecoraro A, Monaco M, Perna F, Sanduzzi A . Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy. Front Immunol. 2019; 10:2812. PMC: 6890605. DOI: 10.3389/fimmu.2019.02812. View